Epigenetic Markers for Molecular Detection of Prostate Cancer

Prostate cancer is a highly prevalent malignancy, which is clinically silent but curable while organ-confined. Because available screening methods show poor sensitivity and specificity, the development of new molecular markers is warranted. Epigenetic alterations, mainly promoter hypermethylation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Vera L., Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2007
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850633/
https://www.ncbi.nlm.nih.gov/pubmed/17325424
http://dx.doi.org/10.1155/2007/356742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850633/
https://www.ncbi.nlm.nih.gov/pubmed/17325424
http://dx.doi.org/10.1155/2007/356742

Ejemplares similares